Ma PC - Search Results

1

Novel targets for therapeutic agents in small cell lung cancer.

Ma PC, Salgia R. Ma PC, et al. J Natl Compr Canc Netw. 2004 Mar;2(2):165-72. doi: 10.6004/jnccn.2004.0014. J Natl Compr Canc Netw. 2004. PMID: 19777705 Review.

2

Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition.

Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Maulik G, et al. Among authors: ma pc. Cytokine Growth Factor Rev. 2002 Feb;13(1):41-59. doi: 10.1016/s1359-6101(01)00029-6. Cytokine Growth Factor Rev. 2002. PMID: 11750879 Review.

3

Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer.

Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R. Maulik G, et al. Among authors: ma pc. Clin Cancer Res. 2002 Feb;8(2):620-7. Clin Cancer Res. 2002. PMID: 11839685

4

Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.

Kijima T, Maulik G, Ma PC, Tibaldi EV, Turner RE, Rollins B, Sattler M, Johnson BE, Salgia R. Kijima T, et al. Among authors: ma pc. Cancer Res. 2002 Nov 1;62(21):6304-11. Cancer Res. 2002. PMID: 12414661

5

Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer.

Maulik G, Madhiwala P, Brooks S, Ma PC, Kijima T, Tibaldi EV, Schaefer E, Parmar K, Salgia R. Maulik G, et al. Among authors: ma pc. J Cell Mol Med. 2002 Oct-Dec;6(4):539-53. doi: 10.1111/j.1582-4934.2002.tb00453.x. J Cell Mol Med. 2002. PMID: 12611639 Free PMC article.

6

Circulating tumor cells and serum tumor biomarkers in small cell lung cancer.

Ma PC, Blaszkowsky L, Bharti A, Ladanyi A, Kraeft SK, Bruno A, Skarin AT, Chen LB, Salgia R. Ma PC, et al. Anticancer Res. 2003 Jan-Feb;23(1A):49-62. Anticancer Res. 2003. PMID: 12683352 Review.

7

c-Met: structure, functions and potential for therapeutic inhibition.

Ma PC, Maulik G, Christensen J, Salgia R. Ma PC, et al. Cancer Metastasis Rev. 2003 Dec;22(4):309-25. doi: 10.1023/a:1023768811842. Cancer Metastasis Rev. 2003. PMID: 12884908 Review.

8

Fibronectin enhances viability and alters cytoskeletal functions (with effects on the phosphatidylinositol 3-kinase pathway) in small cell lung cancer.

Kijima T, Maulik G, Ma PC, Madhiwala P, Schaefer E, Salgia R. Kijima T, et al. Among authors: ma pc. J Cell Mol Med. 2003 Apr-Jun;7(2):157-64. doi: 10.1111/j.1582-4934.2003.tb00214.x. J Cell Mol Med. 2003. PMID: 12927054 Free PMC article.

9

A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.

Sattler M, Pride YB, Ma P, Gramlich JL, Chu SC, Quinnan LA, Shirazian S, Liang C, Podar K, Christensen JG, Salgia R. Sattler M, et al. Cancer Res. 2003 Sep 1;63(17):5462-9. Cancer Res. 2003. PMID: 14500382

10

Mechanisms of metastasis as related to receptor tyrosine kinases in small-cell lung cancer.

Jafri NF, Ma PC, Maulik G, Salgia R. Jafri NF, et al. Among authors: ma pc. J Environ Pathol Toxicol Oncol. 2003;22(3):147-65. doi: 10.1615/jenvpathtoxoncol.v22.i3.10. J Environ Pathol Toxicol Oncol. 2003. PMID: 14529091 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters